CD4 and demyelinating disease: Overall, in the classic TMEV induced biphasic MS models, it remains unclear whether Th2 cytokines play a protective (suppression of pathogenic CD4 Th1 cells) or pathogenic role (by increasing antibody production) in demyelinating disease [52].